期刊文献+

肿瘤微环境影响卵巢癌生物学行为的研究进展 被引量:9

Tumor Microenvironment Affecting Biological Behaviour of Malignant Ovarian Neoplasms: an Update
下载PDF
导出
摘要 肿瘤微环境是一个由肿瘤细胞、基质细胞、细胞因子、免疫细胞等共同构成的肿瘤局部的病理环境,具有组织缺氧、酸中毒、间质高压等特点。肿瘤微环境中大量的生长因子、蛋白水解酶以及免疫炎性反应共同作用于肿瘤细胞表面,对细胞的增殖、转移、分化等产生重要影响。卵巢癌早期症状不典型、转移迅速,预后差,已成为严重威胁妇女健康的肿瘤之一。综述肿瘤微环境与卵巢癌恶性生物学行为的关系。 The tumor microenvironment is a tumor cell,stromal cells,cytokines,immune cells such as tumor constitute the environment of local pathology,which is tissue hypoxia,acidosis,interstitial high pressure and so on.In tumor microenvironment in a large number of growth factors,proteolytic enzymes and the immune inflammatory response which interact on the tumor cell surface,play an important impact on cell proliferation,metastasis,differentiation.Early symptoms of ovarian cancer because of its atypical metastatic quickly,so the prognosis is poor,has become one of the serious threat to women′s health tumor.In this paper the tumor microenvironment and the malignant behavior of ovarian cancer combined with each other,are reviewed.
作者 季芳 狄文
出处 《国际妇产科学杂志》 CAS 2012年第4期352-355,共4页 Journal of International Obstetrics and Gynecology
关键词 卵巢肿瘤 炎症趋化因子类 细胞因子类 细胞外基质 肿瘤微环境 Ovarian neoplasms Chemokines Cytokines Extracellular matrix Tumor microenvironment
  • 相关文献

参考文献1

二级参考文献5

共引文献22

同被引文献91

  • 1王敏,郭丽.卵巢癌患者体内可溶型Fas水平测定及其免疫诊断学意义[J].中华医学研究与实践,2004,2(5):4-5. 被引量:1
  • 2李丙华,徐娅苹.CD_(105)标记微血管密度与喉癌临床病理特征相关性[J].中国耳鼻咽喉头颈外科,2004,11(6):343-345. 被引量:5
  • 3黄智芬,黎汉忠,张作军,施智严.健脾化瘀汤配合化疗治疗晚期大肠癌34例临床观察[J].中国中医药科技,2006,13(6):431-432. 被引量:5
  • 4Hoechst B, Ormandy LA, Ballmaier M, et al. A new population of myeloid-derived suppressor cells in hepatocel: lular carcinoma patients induces CIM CD25 Foxp3 T cells [ J ]. Gastroenterology, 2008,135 ( 1 ) :234-243.
  • 5Lesokhin AM, Hohl TM, Kitano S, et al. MonoeyticCCR2 myeloid- derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment [ J]. Cancer Res,2012,72(4) :876-886.
  • 6Yokoyama I, Waxman F. Differential susceptibility of immunecomp- lexs to release from the erythrocyte CR, receptor by factort [J ]. Mol Immunol, 1994,31 (4) :227.
  • 7Chang B, Liu G, Yang G, et al. REDD1 is required tbr RAS. media ted transformation of human ovarian epithelial cells [ J ]. Cell Cycle ,2009,8 (5) :780-786.
  • 8Kottakis F, Polytarchou C, Foltopoulou P, et al. FGF-2 regulates cell proliferation, migration, and angiogenesis through an NDY1/ KDM2B-mir-101 -EZH2 pathway [ J ]. Molecular Cell, 2011,43 : 285 -298.
  • 9Sharon EJ, Jonathan B, Chen XQ, et al. Polymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the Ovarian Cancer Association consortium [ J ] Twin Res Hum Genet ,2009,12 ( 3 ) :269-275.
  • 10Pouzo MG, Lesurf R, Petkiewicz S, et al. Met induces mammary tunor8 with diverse histologies and. is associated with poor outcome andhuman basal breast cancer [ J ]. Pmc Natl Acad Sci USA,2009,106(31 ) :12903-12908.

引证文献9

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部